Coronary Artery Calcium Score: Imaging Beats Guessing

Every cardiovascular risk calculator does the same thing: it takes population statistics about people who share your age, sex, blood pressure and lipids, and returns the average event rate for that group. It is an actuarial estimate applied to an individual. A coronary artery calcium scan does something categorically different. It looks at your arteries and reports what is actually in them.

What the Scan Measures

Atherosclerotic plaque begins as a soft lipid-rich lesion in the arterial wall. As it matures, calcium is deposited within it. That calcification is dense enough to be visible on computed tomography without contrast, and because calcium in a coronary artery is essentially always within plaque, quantifying it quantifies disease burden.

The scan itself is unremarkable to undergo. It is gated to the cardiac cycle, takes a few minutes, requires no contrast injection, no exercise and no preparation beyond avoiding caffeine in some protocols. Software identifies calcified regions above a density threshold and computes the Agatston score, which weights lesion area by peak density and sums across all four major coronary arteries.

Scores are conventionally banded: zero means no detectable calcified plaque; 1 to 99 is mild; 100 to 399 is moderate; 400 and above is extensive. Absolute score matters, and so does your percentile for age and sex. A score of 80 in a 68-year-old is unremarkable. The same 80 in a 38-year-old is a significant finding that should change management immediately.

The Evidence Base

The Multi-Ethnic Study of Atherosclerosis provided the foundational data. Detrano and colleagues showed that CAC predicted coronary events across four racial and ethnic groups, and did so with predictive power beyond standard risk factors. Subsequent work established that CAC improves risk discrimination and reclassification more than any other widely available add-on test, moving substantial numbers of people across treatment thresholds in both directions.

The reclassification is the point, and it runs both ways. A middle-aged man with borderline lipids and an anxious family history who scores zero has been reassured by evidence rather than by hope. A man with an unremarkable panel who scores 300 has occult disease that no calculator would have caught, and his management should change that day.

The strength of a zero score deserves specific mention. In asymptomatic populations, a zero CAC is associated with very low event rates over the following several years, and this finding has been robust across cohorts. It is not permanent; calcium accumulates and the appropriate interval before rescanning is typically several years depending on risk profile. But as a single negative test in preventive cardiology, it is close to best in class.

Limitations Worth Understanding

That last row confuses people regularly. Statins increase calcium density while reducing events. Calcified plaque is more stable and less likely to rupture than soft plaque. A rising score on treatment therefore does not mean the treatment failed, which is exactly why repeat scanning is not used to judge therapy.

Why This Matters Specifically Here

Standard risk calculators were derived in general populations. They were not built for a 42-year-old who has spent fifteen years on androgens, whose HDL has been suppressed for most of that time, whose blood pressure has been quietly running high, and whose left ventricle is larger than it should be. Baggish and colleagues documented meaningful cardiovascular consequences of long-term illicit anabolic-androgenic steroid use, including effects on ventricular function and coronary atherosclerosis, and the risk profile of that population is not what the calculator assumes.

When the estimating tool does not fit the person in front of you, the argument for direct measurement gets stronger. This is the situation CAC is best suited to: intermediate or uncertain estimated risk, a decision that could go either way, and a patient who would genuinely act on the result. If a zero score would not change what you do, and a score of 400 would not change what you do either, the scan is not worth the radiation.

Who Should Consider It

Broadly, asymptomatic adults at intermediate estimated risk where the decision to start lipid-lowering therapy is genuinely uncertain; people with a strong family history of premature coronary disease; people with elevated lipoprotein(a) wanting to know whether the inherited risk has translated into actual plaque; and people with a long history of compounds known to accelerate atherosclerosis who want a real answer rather than a reassuring one. Age matters: below roughly 40 the yield is low and a zero score is less informative, since disease at that age is more likely to be non-calcified.

This is a decision to make with a physician, not from an article. Availability, cost and local practice vary widely, and in many places the scan is inexpensive and available without a referral, which cuts both ways.

How I Think About It

Under the Tony Huge Laws of Biochemistry Physics, this is the chain bottleneck principle applied to diagnosis. You cannot fix the weak link until you have found it, and estimating where it probably is will never be as good as looking. Every other cardiovascular marker discussed on this site, from ApoB to blood pressure, is a probabilistic input. A calcium score is an observation.

People in this world spend considerable money on compounds whose human evidence base is thin, and then decline a hundred-dollar scan with two decades of outcome data behind it because they would rather not know. That inversion is the actual risk. The scan does not create disease; it reveals whether it is already there, at a point where the answer still changes something.

Where This Fits in the Bigger Picture

Monitoring is the part of enhancement that nobody posts about, and it is the part that decides how long you get to keep doing this. Testing gives you a feedback loop; without one you are guessing with your organs. Start with the Enhanced Athlete Protocol bloodwork guide, then work through the full protocol hub to see how testing, training, nutrition and recovery connect. If you are early in this, the beginners page is the right entry point.

Frequently Asked Questions

What is a coronary artery calcium score?

It is a number derived from a non-contrast CT scan of the heart that quantifies calcified plaque in the coronary arteries. The most common method is the Agatston score, which combines the area and peak density of each calcified lesion across the major coronary arteries into a single total. Higher scores indicate a greater burden of established atherosclerotic disease.

What does a calcium score of zero mean?

It means no calcified coronary plaque was detected, which in an asymptomatic person is associated with a low rate of cardiac events over the following several years. It is reassuring but not absolute: the scan does not detect soft, non-calcified plaque, which is more common in younger people, and calcium can accumulate later, so a zero score reflects the present rather than guaranteeing the future.

Is a CAC scan safe?

The scan involves a low dose of ionising radiation, typically in the region of 1 millisievert, which is broadly comparable to a mammogram and considerably less than a standard diagnostic chest CT. No contrast dye is injected and no exercise is required. As with any imaging, the small radiation exposure should be weighed against the value of the information.

Can a high calcium score be reversed?

Calcium scores generally do not fall, and often rise, including in people taking statins. This is not a sign of failure: lipid-lowering therapy appears to stabilise plaque partly by increasing its calcification, while reducing the risk of events. For this reason repeat scanning is not used to judge whether treatment is working.

Who should get a coronary artery calcium scan?

It is most useful for asymptomatic adults whose estimated cardiovascular risk is intermediate or uncertain and where the result would genuinely change a treatment decision. It is also often considered for those with a family history of premature heart disease or elevated lipoprotein(a). It is not appropriate for people who already have cardiac symptoms, who need evaluation of those symptoms instead.